Assessing the efficacy of a modified assertive community-based treatment programme in a developing country

Botha, Ulla A.; Koen, Liezl; Joska, John A.; Hering, Linda M.; Oosthuizen, Piet P.
January 2010
BMC Psychiatry;2010, Vol. 10, p73
Academic Journal
Background: A number of recently published randomized controlled trials conducted in developed countries have reported no advantage for assertive interventions over standard care models. One possible explanation could be that so-called "standard care" has become more comprehensive in recent years, incorporating some of the salient aspects of assertive models in its modus operandi. Our study represents the first randomised controlled trial assessing the effect of a modified assertive treatment service on readmission rates and other measures of outcome in a developing country. Methods: High frequency service users were randomized into an intervention (n = 34) and a control (n = 26) group. The control group received standard community care and the active group an assertive intervention based on a modified version of the international model of assertive community treatment. Study visits were conducted at baseline and 12 months with demographic and illness information collected at visit 1 and readmission rates documented at study end. Symptomatology and functioning were measured at both visits using the PANSS, CDSS, ESRS, WHO-QOL and SOFAS. Results: At 12 month follow-up subjects receiving the assertive intervention had significantly lower total PANSS (p = 0.02) as well as positive (p < 0.01) and general psychopathology (p = 0.01) subscales' scores. The mean SOFAS score was also significantly higher (p = 0.02) and the mean number of psychiatric admissions significantly lower (p < 0.01) in the intervention group. Conclusions: Our results indicate that assertive interventions in a developing setting where standard community mental services are often under resourced can produce significant outcomes. Furthermore, these interventions need not be as expensive and comprehensive as international, first-world models in order to reduce inpatient days, improve psychopathology and overall levels of functioning in patients with severe mental illness.


Related Articles

  • Applying Burden of Disease Methods in Developing Countries: A Case Study From Pakistan. Hyder, Adnan A.; Morrow, Richard H. // American Journal of Public Health;Aug2000, Vol. 90 Issue 8, p1235 

    Objectives. Disability-adjusted life-year (DALY) and healthy life-year (HeaLY) are composite indicators of disease burden that combine mortality and morbidity into a single measurement. This study examined the application of these methods in a developing country to assess the loss of healthy...

  • Indicative Abstracts of Selected Titles.  // American Journal of Public Health;Dec1995, Vol. 85 Issue 12, p1716 

    This article presents various abstracts related to clinical approaches covered in the December 1995 issue of the journal "American Journal of Public Health." The article "Adult Mortality in Developed Countries: From Description to Explanation," explains patterns of mortality in developed...

  • Clinical Trials of Xenotransplantation: Waiver of the Right to Withdraw from a Clinical Trial Should Be Required. Spillman, Monique A.; Sade, Robert M. // Journal of Law, Medicine & Ethics;Summer2007, Vol. 35 Issue 2, p265 

    Xenotransplantation pits clinical research ethics against public health needs because recipients must undergo long-term, perhaps life-long, surveillance for infectious diseases. This surveillance requirement is effectively an abrogation of the right to withdraw from a clinical trial. Ulysses...

  • Trial design in developing countries. Garner, Paul; Torres, Tessa Tan; Alonso, Pedro // BMJ: British Medical Journal (International Edition);10/1/94, Vol. 309 Issue 6958, p825 

    Focuses on the use of randomized trials with few relevant resources to improve local health services in developing countries. Necessity for intervention trials to be relevant with the needs and services of the area; Consideration on the methods to ensure the usefulness of trials; Impact of...

  • Editorial Commentary: Forecasting When, Where, and Possibly Why Outbreaks Are Likely to Occur. Polgreen, Linnea A.; Polgreen, Philip M. // Clinical Infectious Diseases;Feb2013, Vol. 56 Issue 4, p525 

    The author discusses various factors associated with the outbreak of infectious diseases in different geographic location. The importance of various vaccination programs for children's and financial aid by the government in developing countries for low income people for development of public...

  • Adult Health: A Legitimate Concern for Developing Countries. Phillips, Margaret; Feachem, Richard G. A.; Murray, Christopher J. L.; Over, Mead; Kjellstrom, Tord // American Journal of Public Health;Nov93, Vol. 83 Issue 11, p1527 

    Adults, defined here as people between 15 and 59 years of age, in developing countries have a high risk of premature death and suffer from frequent morbidity and high rates of chronic impairment. Their ill health imposes a major burden on health services and large negative consequences on...

  • Conducting research that is both ethical and responsive to the health needs of a developing country. Joon Wah Mak // International E-Journal of Science, Medicine & Education;2014, Vol. 8 Issue 1, p19 

    There is no substantial difference in conducting research that is both ethical and responsive to the health needs in developing and developed nations. Differences are in financial constraints, technological expertise in identification and addressing needs, and in the perception of equal...

  • Leptospirosis: an emerging global public health problem. Vijayachari, P.; Sugunan, A. P.; Shriram, A. N. // Journal of Biosciences;Nov2008, Vol. 33 Issue 4, p557 

    Leptospirosis has been recognized as an emerging global public health problem because of its increasing incidence in both developing and developed countries. A number of leptospirosis outbreaks have occurred in the past few years in various places such as Nicaragua, Brazil and India. Some of...

  • Old debates rekindled as world AIDS rates escalate. Watanabe, Myrna; Jayaraman, K.S. // Nature Medicine;Sep2003, Vol. 9 Issue 9, p1097 

    Focuses on debates on whether sponsors of HIV prevention trials are obligated to provide treatment to people who become infected during AIDS research trials. Responsibility of sponsors to provide triple therapy; Availability of retrovirals in developing countries; Consideration of the lack of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics